 |
 |
||||||
 |
Our customers' Feedback |
Your CART
$0.00 (0 items)
| |||||
Generic Ezetimibe - Vytorin, Zetia
|
| ||||||||||||
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth.
- Sildenafil citrate and pulmonary arterial hypertension
Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure.
- Fruit and vegetables do not reduce overall cancer risk, review concludes
Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people.
- Common painkillers could be linked to male reproductive disorder
The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study.
Toll FREE US Canada:
+1 800 532 4808
International:
+1 718 313 1498
+44 200 222 7084
MySecureBilling.com certified by:
- FDA rejects new indication for use of combination ezetimibe plus simvastatin ... - Cardiology Today
FDA rejects new indication for use of combination ezetimibe plus simvastatin .
- Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high ... - 7thSpace Interactive (press release)
Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high .
- FDA Rejects Proposed Chronic Kidney Disease Indication for Vytorin - Forbes
FDA Rejects Proposed Chronic Kidney Disease Indication for VytorinForbes25, 2012 – Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the US Food and Drug Administration (FDA) has approved an updated label for VYTORIN ® (ezetimibe/simvastatin) that includes results from the Study of .
- Vytorin's label gets makeover to include SHARP results - Cardiovascular Business
Vytorin's label gets makeover to include SHARP resultsCardiovascular BusinessThe FDA has approved an updated label for Merck's Vytorin (ezetimibe/simvastatin) that includes results from the SHARP trial.
- Entry Point for Hepatitis C Infection Identified - Biomed Middle East
Entry Point for Hepatitis C Infection IdentifiedBiomed Middle EastThe FDA-approved drug ezetimibe (sold under the trade-name Zetia) is readily available and perfectly targeted to the receptor, Sainz said, so the researchers had an ideal method for testing NPC1L1′s involvement in HCV infection.
|
| Copyright 2010. HQDRUGS Ltd. 33 Drugs Pharmacy Network |